Literature DB >> 10102956

The effect of curcumin and placebo on human gall-bladder function: an ultrasound study.

A Rasyid1, A Lelo.   

Abstract

BACKGROUND: The extract of medicinal plants containing curcumin is traditionally believed to have a positive contraction effect on the human gall-bladder. AIMS: To compare the effect of 20 mg curcumin or placebo on the gall-bladder volume of healthy volunteers.
METHODS: A randomized, double blind and crossover design study was carried out in 12 healthy volunteers (seven males and five females). Ultrasonography examination was carried out serially to measure the gall-bladder volume. The data obtained was analysed by paired Student's t-test.
RESULTS: The fasting gall-bladder volumes of 15.74 +/- 4.29 mL on curcumin and 15.98 +/- 4.08 mL on placebo were similar (P > 0.20). The gall-bladder volume was reduced within the period after curcumin administration. The percentage of gall-bladder volume reduction at 0.5, 1.0, 1.5 and 2.0 h after 20 mg curcumin administration were 11.8 +/- 6.9, 16.8 +/- 7.4, 22.0 +/- 8.5 and 29. 3 +/- 8.3%, respectively, which was statistically significant compared to placebo.
CONCLUSION: On the basis of the present findings, it appears that curcumin induces contraction of the human gall-bladder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102956     DOI: 10.1046/j.1365-2036.1999.00464.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  25 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  Evaluation of the Efficacy of Curcumin in the Treatment of Oral Lichen Planus: A Randomized Controlled Trial.

Authors:  Maryam Amirchaghmaghi; Atessa Pakfetrat; Zahra Delavarian; Hanieh Ghalavani; Ala Ghazi
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Authors:  Anna Baghdasaryan; Thierry Claudel; Astrid Kosters; Judith Gumhold; Dagmar Silbert; Andrea Thüringer; Katharina Leski; Peter Fickert; Saul J Karpen; Michael Trauner
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

Review 4.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

Review 5.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

6.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

Review 7.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel.

Authors:  Neelendu Dey; Vitas E Wagner; Laura V Blanton; Jiye Cheng; Luigi Fontana; Rashidul Haque; Tahmeed Ahmed; Jeffrey I Gordon
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

9.  Low dose lipid formulations: effects on gastric emptying and biliary secretion.

Authors:  Greg A Kossena; William N Charman; Clive G Wilson; Bridget O'Mahony; Blythe Lindsay; John M Hempenstall; Christopher L Davison; Patrick J Crowley; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

10.  The effect of curcumin (turmeric) on Alzheimer's disease: An overview.

Authors:  Shrikant Mishra; Kalpana Palanivelu
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.